Category: PRPO

1st Quarter 2019 – Update

1st Quarter 2019 – Update

PRPO – Precipio, Inc. As expected, the reverse split has been completed. So, how far down will we decline? While the company press releases have been positive over the last few months, the underlying fundamentals and financial environment that led to the slow decline, I believe, remains in place. Anticipated in the upcoming few weeks,…

Read More Read More

It’s Inevitable

It’s Inevitable

It’s closing in on a year, March 25th to be exact, of Precipio’s stock price not meeting Nasdaq’s listing price requirement. And it’s now down to the wire for management to make good on their claim in avoiding a reverse split to remain listed on the exchange. So, what now? Apparently, the rumor is that…

Read More Read More

Precipio – Undervalued?

Precipio – Undervalued?

According to Merriam-Webster, the definition of undervalue is a verb meaning: to value, rate, or estimate below the real worth. So does this apply to Precipio? At this current point in November, I would say it does. Precipio, Inc. is a growing company in the burgeoning liquid biopsy space that is visibly executing a strategy…

Read More Read More

3rd Quarter 2018 – Portfolio Update

3rd Quarter 2018 – Portfolio Update

The year has been pretty positive so far with the markets and economy showing impressive gains. Hope you as well are being rewarded with gains. Below are my updates on my picks for the third quarter.   TRXC – TransEnterix is still showing signs of decent growth. The new addition of a commercial officer should…

Read More Read More

Portfolio Update – XXII and PRPO

Portfolio Update – XXII and PRPO

As is customary with any semi-active trader, periodic review of the companies in your portfolio is both critically and obviously important to maintain meaningful growth. In other words, I think of each portfolio dollar as an employee of my company. As manager, you want to move employees into areas where they each will continue to…

Read More Read More

Precipio, Inc. – PRPO

Precipio, Inc. – PRPO

I’ve been watching the ebb and flow of the market, keeping an eye out for potential accelerated growth candidates and have identified a possible gem. This pick is Precipio, Inc. (PRPO). This small cap company is in the business of providing cancer diagnostic products and services to the oncology market. Precipio is expanding the potential…

Read More Read More